Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2007-02-16
2010-11-23
Chong, Yong S (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S568000
Reexamination Certificate
active
07838556
ABSTRACT:
The present invention generally relates to pharmaceutical compositions comprising ethers of 3-hydroxyphenylacetic acid. The present invention also relates to therapeutic uses of the ethers of 3-hydroxyphenylacetic acid. The ethers of 3-hydroxyphenylacetic acid have the chemical structural of formula (I):where R is an aromatic or arylalkyl substituent.
REFERENCES:
patent: 4062895 (1977-12-01), Marshall
patent: 4738985 (1988-04-01), Kluger et al.
patent: 4983632 (1991-01-01), Gessa et al.
patent: 5380937 (1995-01-01), Koehler et al.
patent: 5990162 (1999-11-01), Scharf
patent: 6204245 (2001-03-01), Siegel et al.
patent: 6436998 (2002-08-01), Cacciaglia et al.
patent: 6472431 (2002-10-01), Cook et al.
patent: 6623730 (2003-09-01), Williams et al.
patent: 6770784 (2004-08-01), Cacciaglia et al.
patent: 6780889 (2004-08-01), Cook et al.
Pharmaceutical Dosage Forms, vol. 2; Tablets—Lieberman, Herbert A.; New York, Dekker, Inc. 1990.
Chen, Weibin et. al.; Bioorganic & Medicinal Chemistry Letters 15 (2005) 3201-3202.
Chen et al,Bioorganic&Medicinal Chemistry Letters, 15:3201-3202 (2005).
Guin Ting Wong et al,Trends in Pharmacological Sciences, 25(1):29-34 (2004).
Nicholson et al,Drug and Alcohol Dependence, 63:1-22 (2001).
Bernasconi et al,TiPS, 20:135-141 (1999).
Carai et al,European Journal of Pharmacology, 428:315-321 (2001).
Cammalleri et al,Neurophyschopharmacology, 27(6):960-969 (2002).
Wu et al,The Journal of Pharmacology and Experimental Therapeutics, 305(2):675-679 (2003).
Bourguignon et al,Alcohol, 20:227-236 (2000).
Waszkielewicz et al,Polish Journal of Pharmacology, 56:43-49 (2004).
Macias et al,Bioorganic and Medicinal Chemistry, 12:1643-1647 (2004).
Carter et al,The Journal of Pharmacology and Experimental Therapeutics, 313(3):1314-1323 (2005).
Renaud et al,J. Med. Chem., 48:364-379 (2005).
Mehta et al,The Journal of Pharmacology and Experimental Therapeutics, 299(3):1148-1153 (2001).
Wilson,HSC NEWS, News Releases, vol. XXXVIII, Issue 47 (Nov. 22, 2005).
“m-Hydroxyphenylacetic Acid”, ChemFinder.com, Database & Internet Searching (Jan. 8, 2006).
Coop Andrew
France Charles P.
Ticku Maharaj K.
Board of Regents , The University of Texas System
Chong Yong S
Morgan & Lewis & Bockius, LLP
University of Maryland Baltimore
LandOfFree
Ethers of 3-hydroxyphenylacetic acid as selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ethers of 3-hydroxyphenylacetic acid as selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ethers of 3-hydroxyphenylacetic acid as selective... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4250349